Skip to main content
. 2020 Feb 27;29(5):514–522. doi: 10.1177/0961203320908932

Table 2.

Clinical characteristics of SLE patients with cSLE versus late-onset SLE

Clinical items At diagnosis
p-Value Ever
p-Value
cSLE (N = 57) Late-onset SLE (N = 135) cSLE (N = 57) Late-onset SLE (N = 135)
Arthritis, n (%) 35 (61.4) 95 (70.4) 0.22 45 (78.9) 109 (80.8) 0.77
Acute cutaneous lupus, n (%) 41 (71.9) 84 (62.2) 0.19 47 (82.4) 87 (64.4) 0.013
Chronic cutaneous lupus, n (%) 6 (10.5) 15 (11.1) 0.90 6 (10.5) 15 (11.1) 0.90
Oral/nasal ulcers, n (%) 12 (21.1) 13 (9.6) 0.055 20 (35.1) 18 (13.3) <0.001
Non-scarring alopecia, n (%) 12 (21.2) 24 (17.8) 0.59 22 (38.6) 31 (23.0) 0.026
Lupus nephritis, n (%) 8 (14.0) 19(14.1) 0.46 22 (38.6) 24 (17.8) 0.002
Primary NPSLE, n (%) 7 (12.3) 19 (14.1) 0.74 10 (17.6) 23 (17.1) 0.93
Serositis, n (%) 9 (15.8) 23 (17.0) 0.83 10 (17.6) 29 (21.4) 0.53
Leucopaenia, n (%) 19 (33.3) 31 (23.0) 0.13 26 (45.6) 43 (31.9) 0.07
Thrombocytopaenia, n (%) 7 (12.3) 21 (15.6) 0.55 13 (22.8) 24 (17.8) 0.42
Raynaud’s, n (%) 17 (29.8) 50 (36.3) 0.33 21 (36.8) 51 (37.0) 0.90
Fever, n (%) 23 (40.4) 17 (12.6) <0.0001 25 (43.9) 20 (14.8) <0.001

Statistically significant values are shown in bold.

SLE: systemic lupus erythematosus; cSLE: childhood-onset SLE.